Source: New feed
Biotech M&A Trade Hits a Snag
Wall Street Journal (subscription) (blog)
Who said day trading was easy money? Certainly not biotech investors after Monday afternoon's price action. Shares of cancer drug developer were halted for pending news late in the trading day. Investors had long speculated about Tesaro, whose shares ...